NO20005698L - Nye 1,2,5-trisubstituerte 1,2-dihydro-indazol-3-oner med antiastmatisk, antiallergisk, betennelseshemmende, immunomodulerende og neuroprotektiv virkning, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel - Google Patents
Nye 1,2,5-trisubstituerte 1,2-dihydro-indazol-3-oner med antiastmatisk, antiallergisk, betennelseshemmende, immunomodulerende og neuroprotektiv virkning, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddelInfo
- Publication number
- NO20005698L NO20005698L NO20005698A NO20005698A NO20005698L NO 20005698 L NO20005698 L NO 20005698L NO 20005698 A NO20005698 A NO 20005698A NO 20005698 A NO20005698 A NO 20005698A NO 20005698 L NO20005698 L NO 20005698L
- Authority
- NO
- Norway
- Prior art keywords
- asthmatic
- indazol
- trisubstituted
- immunomodulatory
- medicaments
- Prior art date
Links
- -1 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones Chemical class 0.000 title 1
- 230000003266 anti-allergic effect Effects 0.000 title 1
- 230000001088 anti-asthma Effects 0.000 title 1
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 239000000924 antiasthmatic agent Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002519 immonomodulatory effect Effects 0.000 title 1
- 230000000324 neuroprotective effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19821003A DE19821003A1 (de) | 1998-05-11 | 1998-05-11 | Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP1999/002291 WO1999058504A1 (de) | 1998-05-11 | 1999-04-01 | Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver wirkung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005698D0 NO20005698D0 (no) | 2000-11-10 |
| NO20005698L true NO20005698L (no) | 2001-01-08 |
Family
ID=7867363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005698A NO20005698L (no) | 1998-05-11 | 2000-11-10 | Nye 1,2,5-trisubstituerte 1,2-dihydro-indazol-3-oner med antiastmatisk, antiallergisk, betennelseshemmende, immunomodulerende og neuroprotektiv virkning, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6180637B1 (no) |
| EP (1) | EP1077948A1 (no) |
| JP (1) | JP2002514627A (no) |
| KR (1) | KR20010025011A (no) |
| CN (1) | CN1309642A (no) |
| AR (1) | AR018605A1 (no) |
| AU (1) | AU745796B2 (no) |
| BG (1) | BG104910A (no) |
| BR (1) | BR9911772A (no) |
| CA (1) | CA2271837A1 (no) |
| CO (1) | CO5021131A1 (no) |
| DE (1) | DE19821003A1 (no) |
| HK (1) | HK1038751A1 (no) |
| HU (1) | HUP0101707A3 (no) |
| IL (1) | IL139358A0 (no) |
| NO (1) | NO20005698L (no) |
| NZ (1) | NZ508646A (no) |
| PL (1) | PL344254A1 (no) |
| SK (1) | SK17082000A3 (no) |
| TR (1) | TR200003302T2 (no) |
| TW (1) | TW448163B (no) |
| WO (1) | WO1999058504A1 (no) |
| ZA (1) | ZA200006151B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
| US6417189B1 (en) * | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
| WO2008141385A1 (en) * | 2007-05-21 | 2008-11-27 | Biota Scientific Management Pty Ltd | Viral polymerase inhibitors |
| MX355309B (es) | 2011-03-14 | 2018-04-16 | Boehringer Ingelheim Int | Inhibidores de benzodioxano de la produccion de leucotrieno. |
| WO2013012844A1 (en) | 2011-07-19 | 2013-01-24 | Boehringer Ingelheim International Gmbh | Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase |
| AR091315A1 (es) | 2012-03-06 | 2015-01-28 | Boehringer Ingelheim Int | Inhibidores de benzodioxano de la produccion de leucotrieno |
| JP6080226B2 (ja) | 2012-03-06 | 2017-02-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 他の活性物質と組み合わせたロイコトリエン産生阻害用ベンゾジオキサン |
| US9403830B2 (en) | 2012-07-17 | 2016-08-02 | Boehringer Ingelheim International Gmbh | Inhibitors of leukotriene production |
| WO2015009609A1 (en) | 2013-07-15 | 2015-01-22 | Boehringer Ingelheim International Gmbh | Inhibitors of leukotriene production |
| EP3022194B1 (en) | 2013-07-15 | 2017-05-17 | Boehringer Ingelheim International GmbH | Inhibitors of leukotriene production |
| CN110300581B (zh) * | 2016-06-08 | 2023-09-08 | 善睿圣医药保健股份有限公司 | 具有奇数碳的脂类化合物及其作为医药组合物或者营养补充剂的用途 |
| CN113105409B (zh) * | 2021-04-06 | 2023-06-02 | 四川大学 | 2-(羟基苄基)苯并[d]异噻唑酮类化合物、其制备方法和用途 |
| AU2022376563A1 (en) | 2021-11-01 | 2023-12-07 | Alkahest, Inc. | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3132916A1 (de) * | 1981-08-20 | 1983-03-03 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 1-phenylindazol-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US5179112A (en) * | 1985-04-17 | 1993-01-12 | Ici Americas Inc. | Heterocyclic amide derivatives and pharmaceutical use |
| IL84944A (en) * | 1987-01-19 | 1992-02-16 | Ici Plc | Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation |
| US5036083A (en) * | 1988-07-15 | 1991-07-30 | Ici Pharma | Heterocyclic agents |
| US5229408A (en) * | 1988-07-15 | 1993-07-20 | Ici Pharma | 4-carbamoyl-1,2-dihydro-3H-indazol-3-one derivatives |
| DE19610882A1 (de) * | 1996-03-20 | 1997-09-25 | Dresden Arzneimittel | Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
1998
- 1998-05-11 DE DE19821003A patent/DE19821003A1/de not_active Withdrawn
-
1999
- 1999-04-01 WO PCT/EP1999/002291 patent/WO1999058504A1/de not_active Ceased
- 1999-04-01 HK HK02100376.2A patent/HK1038751A1/zh unknown
- 1999-04-01 BR BR9911772-0A patent/BR9911772A/pt not_active IP Right Cessation
- 1999-04-01 NZ NZ508646A patent/NZ508646A/xx unknown
- 1999-04-01 JP JP2000548308A patent/JP2002514627A/ja active Pending
- 1999-04-01 KR KR1020007012614A patent/KR20010025011A/ko not_active Withdrawn
- 1999-04-01 HU HU0101707A patent/HUP0101707A3/hu unknown
- 1999-04-01 PL PL99344254A patent/PL344254A1/xx unknown
- 1999-04-01 SK SK1708-2000A patent/SK17082000A3/sk unknown
- 1999-04-01 IL IL13935899A patent/IL139358A0/xx unknown
- 1999-04-01 EP EP99950343A patent/EP1077948A1/de not_active Withdrawn
- 1999-04-01 AU AU42576/99A patent/AU745796B2/en not_active Ceased
- 1999-04-01 CN CN99808515A patent/CN1309642A/zh active Pending
- 1999-04-01 TR TR2000/03302T patent/TR200003302T2/xx unknown
- 1999-04-23 TW TW088106565A patent/TW448163B/zh not_active IP Right Cessation
- 1999-05-05 US US09/305,602 patent/US6180637B1/en not_active Expired - Fee Related
- 1999-05-07 CO CO99028290A patent/CO5021131A1/es unknown
- 1999-05-11 CA CA002271837A patent/CA2271837A1/en not_active Abandoned
- 1999-05-11 AR ARP990102212A patent/AR018605A1/es not_active Application Discontinuation
-
2000
- 2000-10-31 ZA ZA200006151A patent/ZA200006151B/en unknown
- 2000-11-03 BG BG104910A patent/BG104910A/xx unknown
- 2000-11-10 NO NO20005698A patent/NO20005698L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999058504A9 (de) | 2000-02-03 |
| TW448163B (en) | 2001-08-01 |
| BR9911772A (pt) | 2001-02-06 |
| CA2271837A1 (en) | 1999-11-11 |
| US6180637B1 (en) | 2001-01-30 |
| AU4257699A (en) | 1999-11-29 |
| TR200003302T2 (tr) | 2001-02-21 |
| EP1077948A1 (de) | 2001-02-28 |
| IL139358A0 (en) | 2001-11-25 |
| AR018605A1 (es) | 2001-11-28 |
| HUP0101707A2 (hu) | 2002-03-28 |
| WO1999058504A1 (de) | 1999-11-18 |
| ZA200006151B (en) | 2000-12-06 |
| CO5021131A1 (es) | 2001-03-27 |
| AU745796B2 (en) | 2002-03-28 |
| NZ508646A (en) | 2002-11-26 |
| CN1309642A (zh) | 2001-08-22 |
| NO20005698D0 (no) | 2000-11-10 |
| HK1038751A1 (zh) | 2002-03-28 |
| JP2002514627A (ja) | 2002-05-21 |
| HUP0101707A3 (en) | 2002-06-28 |
| PL344254A1 (en) | 2001-10-22 |
| DE19821003A1 (de) | 1999-11-18 |
| BG104910A (en) | 2001-06-29 |
| KR20010025011A (ko) | 2001-03-26 |
| SK17082000A3 (sk) | 2001-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO954942L (no) | Nye erytromycinderivater, fremgangsmåte for deres fremstilling og anvendelse av derivatene som legemidler | |
| NO20015113L (no) | Nye forbindelser, deres fremstilling og anvendelse | |
| NO964654D0 (no) | Nye erytromycinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler | |
| NO20015156D0 (no) | 5-pyridyl-1,3-Azol forbindelser, fremgangsmåte for produksjon av de samme og deres anvendelse | |
| AU2003233010A8 (en) | Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof | |
| NO20020684L (no) | 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler | |
| NO20005266L (no) | Nye substituerte amider, deres fremstilling og anvendelse | |
| NO20005698D0 (no) | Nye 1,2,5-trisubstituerte 1,2-dihydro-indazol-3-oner med antiastmatisk, antiallergisk, betennelseshemmende, immunomodulerende og neuroprotektiv virkning, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel | |
| DE60001307D1 (de) | Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung | |
| NO20005699L (no) | Nye 1,5- og 3-0-substituerte 1H-indazoler med antiastmatisk, antiallergisk, betennelseshemmende, immunomodulerende og neuroprotektiv virkning, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel | |
| NO20022021D0 (no) | Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler | |
| DK1004592T3 (da) | Nye erythromycinderivater, deres fremstilling og deres anvendelse som medikamenter | |
| DE60006958D1 (de) | Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen | |
| ATE312828T1 (de) | Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung | |
| NO20052124D0 (no) | Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse | |
| NO20015058L (no) | Nye ribose-substituerte aromatiske amider, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler | |
| NO984624L (no) | Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav | |
| NO940130D0 (no) | Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav | |
| NO971424D0 (no) | Nye heterocyklisk substituerte imidazolo-kinoksalidoner, deres fremstilling og anvendelse | |
| NO980929D0 (no) | Nye benzoksazindionderivater, fremgangsmåte for deres fremstilling og deres anvendelse | |
| NO982105D0 (no) | Nye mellomprodukter og deres anvendelse for fremstilling av N,N'-broslÕtte bisindolylmaleimider | |
| NO20023188L (no) | Nye heteroarylderivater, deres fremstilling og anvendelse | |
| DE60002891D1 (de) | Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen | |
| NO963129D0 (no) | Nye leukotrien-B4-derivater, fremgangsmåte for fremstilling derav og anvendelse derav som legemidler | |
| DK1235809T3 (da) | Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazociner og deres anvendelse som lægemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |